Berger Financial Group’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,067
Closed -$210K 484
2025
Q4
$210K Buy
+2,067
New +$166K 0.01% 445
2023
Q3
Sell
-2,418
Closed -$227K 282
2023
Q2
$227K Buy
+2,418
New +$189K 0.03% 260
2021
Q4
Sell
-2,653
Closed -$253K 258
2021
Q3
$253K Sell
2,653
-35
-1% -$3.69K 0.05% 180
2021
Q2
$334K Hold
2,688
0.06% 146
2021
Q1
$354K Hold
2,688
0.08% 138
2020
Q4
$356K Buy
+2,688
New +$325K 0.06% 148

Other funds holding EXAS

Berger Financial Group's EXAS Position: Q1 2026 in Review

Berger Financial Group sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 2,067 shares — an estimated $210K sold.

Berger Financial Group first reported a position in EXAS in Q4 2020 and held it in 6 quarters. The position peaked at $356K in Q4 2020. 6 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Berger Financial Group reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Berger Financial Group sold 2,067 Exact Sciences shares in Q1 2026, an estimated $210K.
  • Berger Financial Group first reported a position in Exact Sciences in Q4 2020 and held it in 6 quarters.
  • Berger Financial Group's Exact Sciences position peaked at $356K in Q4 2020.
  • 6 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Berger Financial Group's 13F filing for Q1 2026, filed 28 Apr 2026.